|
US4904411A
(en)
*
|
1986-04-25 |
1990-02-27 |
Ceramics Process Systems Corp. |
Highly loaded, pourable suspensions of particulate materials
|
|
US5104742A
(en)
*
|
1989-05-10 |
1992-04-14 |
Ashland Oil, Inc. |
Water based coating for roughened metal surfaces
|
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
US5705187A
(en)
*
|
1989-12-22 |
1998-01-06 |
Imarx Pharmaceutical Corp. |
Compositions of lipids and stabilizing materials
|
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
|
US5209720A
(en)
*
|
1989-12-22 |
1993-05-11 |
Unger Evan C |
Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
|
|
US5230882A
(en)
*
|
1989-12-22 |
1993-07-27 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US6001335A
(en)
*
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
|
US5334381A
(en)
*
|
1989-12-22 |
1994-08-02 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
|
US20020150539A1
(en)
*
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
|
US5228446A
(en)
*
|
1989-12-22 |
1993-07-20 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
|
US5585112A
(en)
*
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
|
US6088613A
(en)
*
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
|
US5656211A
(en)
*
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
|
US5088499A
(en)
*
|
1989-12-22 |
1992-02-18 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
|
US5305757A
(en)
*
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
|
US5149319A
(en)
*
|
1990-09-11 |
1992-09-22 |
Unger Evan C |
Methods for providing localized therapeutic heat to biological tissues and fluids
|
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
|
US5123414A
(en)
*
|
1989-12-22 |
1992-06-23 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
|
GB9027371D0
(en)
*
|
1990-12-18 |
1991-02-06 |
Exxon Chemical Patents Inc |
Coating compositions
|
|
US5126062A
(en)
*
|
1991-01-15 |
1992-06-30 |
Nch Corporation |
Calcium sulfonate grease and method of manufacture
|
|
US5874062A
(en)
*
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
|
US5325860A
(en)
*
|
1991-11-08 |
1994-07-05 |
Mayo Foundation For Medical Education And Research |
Ultrasonic and interventional catheter and method
|
|
EP1104678A2
(de)
|
1992-05-04 |
2001-06-06 |
UNGER, Evan C |
Verfahren zur Hypothermische Verstärkung von Gewebe
|
|
US5338347A
(en)
*
|
1992-09-11 |
1994-08-16 |
The Lubrizol Corporation |
Corrosion inhibition composition
|
|
EP0789399B1
(de)
*
|
1993-01-12 |
2001-11-07 |
Sony Corporation |
Ausgangsschaltung für Ladungsübertragungselement
|
|
WO1995014528A1
(en)
*
|
1993-11-22 |
1995-06-01 |
Angus Chemical Company |
Bis-oxazolidine compounds and their use
|
|
US7083572B2
(en)
*
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
|
US5736121A
(en)
*
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
|
US5830430A
(en)
*
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
|
US6139819A
(en)
*
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
|
CA2252617A1
(en)
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
|
DE69718519T2
(de)
*
|
1996-09-11 |
2003-11-06 |
Imarx Pharmaceutical Corp., Tucson |
Verbesserte verfahren zur diagnostischen bilderzeugung unter verwendung eines kontrastmittels und eines vasodilators
|
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
|
US6537246B1
(en)
*
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
|
US6090800A
(en)
*
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
|
US20050019266A1
(en)
*
|
1997-05-06 |
2005-01-27 |
Unger Evan C. |
Novel targeted compositions for diagnostic and therapeutic use
|
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
|
US6884230B1
(en)
|
1998-03-09 |
2005-04-26 |
Baxter International Inc. |
Dispensing head for a tissue sealant applicator and process of use
|
|
US6921380B1
(en)
|
1998-10-01 |
2005-07-26 |
Baxter International Inc. |
Component mixing catheter
|
|
US6432084B1
(en)
*
|
1999-05-07 |
2002-08-13 |
Baxter International Inc. |
Non-newtonian fluid spray applicator and method
|
|
EP2343047B2
(de)
|
2000-02-08 |
2021-03-17 |
Rice University |
Optisch aktive Nanopartikel zur Verwendung in Therapie- und Diagnoseverfahren
|
|
US20030133972A1
(en)
*
|
2000-10-11 |
2003-07-17 |
Targesome, Inc. |
Targeted multivalent macromolecules
|
|
US20030129223A1
(en)
*
|
2000-10-11 |
2003-07-10 |
Targesome, Inc. |
Targeted multivalent macromolecules
|
|
DK1377320T3
(da)
|
2001-04-04 |
2009-02-09 |
Nordic Vaccine Technology As |
Polynukleotidbindingskomplekser omfattende steroler og saponiner
|
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
|
US20060147509A1
(en)
*
|
2002-10-02 |
2006-07-06 |
Kirkby Nikolai S |
Composition for vaccination
|
|
WO2005092286A2
(en)
*
|
2004-03-29 |
2005-10-06 |
The University Of Houston System |
Metallic nano-particles and discrete polymer-coated nano-particles
|
|
WO2007115134A2
(en)
|
2006-03-29 |
2007-10-11 |
Wayne State University |
Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
|
|
EP2020988B1
(de)
|
2006-04-28 |
2017-08-16 |
Children's Hospital Medical Center |
Zusammensetzungen mit fusogenen proteinen oder polypeptiden aus prosaposin zur anwendung auf transmembrane wirkstofffreisetzungssysteme
|
|
KR100820408B1
(ko)
*
|
2006-08-09 |
2008-04-10 |
현대자동차주식회사 |
방청왁스 조성물
|
|
US20110130444A1
(en)
*
|
2007-05-04 |
2011-06-02 |
Stefan Moisyadi |
Methods and compositions for targeted delivery of gene therapeutic vectors
|
|
AU2009236585B2
(en)
|
2008-04-18 |
2013-03-07 |
Vaxinnate Corporation |
Deletion mutants of flagellin and methods of use
|
|
ES2613885T3
(es)
|
2009-11-04 |
2017-05-26 |
Ssw Holding Company, Inc. |
Superficies de aparatos de cocción que tienen un patrón de confinamiento de salpicaduras y procedimientos de fabricación de las mismas
|
|
EP2741784B1
(de)
|
2011-03-02 |
2017-05-17 |
Board Of Regents, The University Of Texas System |
Tusc2 therapien
|
|
US9976102B2
(en)
|
2011-10-31 |
2018-05-22 |
Nch Corporation |
Composition and method of manufacturing calcium sulfonate greases using alkali metal hydroxide and delayed addition of non-aqueous converting agents
|
|
US9458406B2
(en)
|
2011-10-31 |
2016-10-04 |
Nch Corporation |
Calcium hydroxyapatite based sulfonate grease compositions and method of manufacture
|
|
KR101797940B1
(ko)
|
2011-10-31 |
2017-11-15 |
엔씨에이취 코오포레이션 |
수산화인회석칼슘계 설폰산칼슘 그리스 조성물 및 제조 방법
|
|
US9976101B2
(en)
|
2011-10-31 |
2018-05-22 |
Nch Corporation |
Method of manufacturing calcium sulfonate greases using delayed addition of non-aqueous converting agents
|
|
CN103565745A
(zh)
|
2012-08-10 |
2014-02-12 |
德克萨斯州大学系统董事会 |
用于治疗中风的神经保护性脂质体组合物和方法
|
|
US9963607B2
(en)
|
2014-03-06 |
2018-05-08 |
Hewlett-Packard Development Company, L.P. |
Non-Newtonian inkjet inks
|
|
WO2015134026A1
(en)
*
|
2014-03-06 |
2015-09-11 |
Hewlett-Packard Development Company, L.P. |
Non-newtonian inkjet inks
|
|
CN108601765A
(zh)
|
2015-12-18 |
2018-09-28 |
德克萨斯州大学系统董事会 |
用于早产管理的治疗剂
|
|
US10392577B2
(en)
|
2016-05-18 |
2019-08-27 |
Nch Corporation |
Composition and method of manufacturing overbased sulfonate modified lithium carboxylate grease
|
|
US10087388B2
(en)
|
2016-05-18 |
2018-10-02 |
Nch Corporation |
Composition and method of manufacturing calcium sulfonate and calcium magnesium sulfonate greases using a delay after addition of facilitating acid
|
|
US10519393B2
(en)
|
2016-05-18 |
2019-12-31 |
Nch Corporation |
Composition and method of manufacturing calcium magnesium sulfonate greases
|
|
US10087387B2
(en)
|
2016-05-18 |
2018-10-02 |
Nch Corporation |
Composition and method of manufacturing calcium magnesium sulfonate greases
|
|
US10087391B2
(en)
|
2016-05-18 |
2018-10-02 |
Nch Corporation |
Composition and method of manufacturing calcium magnesium sulfonate greases without a conventional non-aqueous converting agent
|
|
CA3040458A1
(en)
|
2016-10-12 |
2018-04-19 |
Board Of Regents, The University Of Texas System |
Methods and compositions for tusc2 immunotherapy
|
|
MY201466A
(en)
|
2017-10-26 |
2024-02-24 |
Syed Taymur Ahmad |
Composition comprising non-newtonian fluids for hydrophobic, oleophobic, and oleophilic coatings, and methods of using the same
|
|
WO2019118826A1
(en)
|
2017-12-15 |
2019-06-20 |
Board Of Regents, The University Of Texas System |
Methods and compositions for treating cancer using exosomes-associated gene editing
|
|
EP3768246B1
(de)
|
2018-03-23 |
2021-08-25 |
Bexion Pharmaceuticals, Inc. |
Pharmazeutische zusammensetzungen von saposin c und deren verwendung zur behandlung von krebs
|
|
AU2019242912B2
(en)
|
2018-03-28 |
2025-07-17 |
Board Of Regents, The University Of Texas System |
Identification of epigenetic alterations in DNA isolated from exosomes
|
|
WO2020086701A1
(en)
|
2018-10-24 |
2020-04-30 |
Codiak Biosciences, Inc. |
Methods to improve potency of electroporation
|
|
US12331261B2
(en)
|
2018-11-20 |
2025-06-17 |
Nch Corporation |
Composition and method of manufacturing sulfonate-based greases using a glycerol derivative
|
|
KR20210125530A
(ko)
|
2019-02-08 |
2021-10-18 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
노화 및 연령-관련 기관 기능부전과 연관된 질환을 치료하기 위한 텔로머라제-함유 엑소좀
|
|
US11661563B2
(en)
|
2020-02-11 |
2023-05-30 |
Nch Corporation |
Composition and method of manufacturing and using extremely rheopectic sulfonate-based greases
|
|
CN115996707A
(zh)
|
2020-04-20 |
2023-04-21 |
德克萨斯大学系统董事会 |
生物活性干粉组合物及其制造和使用方法
|
|
WO2022040435A1
(en)
|
2020-08-19 |
2022-02-24 |
The Board Of Regents Of The University Of Texas System |
Nanodrugs for targeted drug delivery and use thereof
|
|
WO2022155500A1
(en)
|
2021-01-14 |
2022-07-21 |
Senti Biosciences, Inc. |
Secretable payload regulation
|
|
EP4519366A1
(de)
*
|
2022-05-05 |
2025-03-12 |
Basf Se |
Zusammensetzung, herstellung und verwendung
|
|
JP2025521120A
(ja)
|
2022-05-18 |
2025-07-08 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
遺伝子発現の誘導性選択的スプライシング調節のための組成物および方法
|